December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Immunohistochemical Characterization of Cells in Rabbit Vitreous following treatment with Vitrase®
Author Affiliations & Notes
  • WS Craig
    Research & Product Development ISTA
  • PF Glidden
    Research & Product Development ISTA
  • C Kenney
    Ophthalmology Research Cedars-Sinai Medical Center Los Angeles CA
  • EC Collins
    Research & Product Development ISTA
  • RW Lambert
    Research & Product Development ISTA
  • Footnotes
    Commercial Relationships    W.S. Craig, ISTA Pharmaceuticals, Inc. E; P.F. Glidden, ISTA Pharmaceuticals E; C. Kenney, ISTA Pharmaceuticals C; E.C. Collins, ISTA Pharmaceuticals E; R.W. Lambert, ISTA Pharmaceuticals E.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 3282. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      WS Craig, PF Glidden, C Kenney, EC Collins, RW Lambert; Immunohistochemical Characterization of Cells in Rabbit Vitreous following treatment with Vitrase® . Invest. Ophthalmol. Vis. Sci. 2002;43(13):3282.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose:The purpose of the study was to identify cells that migrate into the posterior segment of the rabbit eye after intravitreous injection of Vitrase. Methods:Eighteen rabbits were examined by indirect ophthalmoscopy (I.O.) and slit-lamp biomicroscopy. The animals were anesthetized and sixteen rabbits (N=16) received intravitreous injections of 75 IU of Vitrase, OU (equivalent to twice the human clinical dose). Two rabbits from this group were randomly selected on Days 0, 1, 2, 4, 7, 10, 14 and 28 and re-examined by I.O. and slit lamp biomicroscopy. The animals were then sacrificed and the eyes were enucleated and processed for paraffin sectioning and immunohistochemical staining. The remaining animals received either sham injections into the vitreous (N=1) or saline injections (N=1), OU, sacrificed, enucleated and tissue was taken for processing. Tissue sections were probed with antibodies specific to rabbit activated macrophages, T-lymphocytes and B-lymphocytes. Results:Ophthalmoscopic observations of eyes injected with Vitrase identified haze and cells in the vitreous 2 - 28 days following injection. These are clinical indicators of an inflammatory response. The cells were observed by light microscopy, in the body of the vitreous and near the retina. Immunohistochemical staining showed that these cells were composed of activated macrophages, T-cell lymphocytes and B-cell lymphocytes. Activated macrophages were present on Day 2, and all cell types appeared by Day 4 and became more numerous through Day 14. At Day 28, microscopic and ophthalmoscopic observations showed that the cellular response in the posterior segment was diminished to levels observed at Day 4. Conclusion: The presence of macrophages in the vitreous suggests that the initial inflammatory response by the rabbit following a single Vitrase injection is cellular in nature. The presence of T-lymphocytes and B-lymphocytes suggests the possibility that a humoral response may be elicited, but this has not been observed in other species.

Keywords: 629 vitreous 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.